Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sangamo Therapeutics (SGMO) Change in Taxes (2024)

Historic Change in Taxes for Sangamo Therapeutics (SGMO) over the last 1 years, with Q4 2024 value amounting to $39000.0.

  • Sangamo Therapeutics' Change in Taxes changed N/A to $39000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was $39000.0, marking a year-over-year change of. This contributed to the annual value of -$556000.0 for FY2024, which is 11490.22% down from last year.
  • Sangamo Therapeutics' Change in Taxes amounted to $39000.0 in Q4 2024.
  • Sangamo Therapeutics' 5-year Change in Taxes high stood at $1.4 million for Q1 2024, and its period low was -$2.5 million during Q2 2024.